A L Gvozdkov

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Efficacy and safety were studied of nonfractionated versus low-molecular heparines (NFH, LMH) in acute myocardial infarction (AMI). A total of 99 AMI patients entered the trial including those after thrombolytic therapy. The highest preventive effect in respect to both venous and arterial thrombosis was achieved at subcutaneous administration of NFH in(More)
  • 1